Orebro Musculoskeletal Screening Questionnaire-12

Musculoskeletal Injury Clinical Trial

Official title:

Evaluation of Turkish Validity, Reliability and Practicality of Örebro Musculoskeletal System Screening Questionnaire-12

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04723615
• Other study ID #: 2020/469
• Status: Active, not recruiting
• Start date: December 18, 2020
• Est. completion date: December 18, 2024

Study information

• Verified date: January 2022
• Source: Afyonkarahisar Health Sciences University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The research is a study with methodological design. The validity, reliability and practicality of the Örebro Musculoskeletal System Screening Questionnaire-12 will be investigated. In this context, a questionnaire will be applied to the participants to take part in the study after the translation process is completed.

Description:

Musculoskeletal disorders are quite common in developed and developing countries. Musculoskeletal disorders cause economic burdens in the individual and social field. In addition, getting reports is one of the main causes of reduced productivity and work disability. Therefore, inexpensive and easily applicable screening questionnaires are needed to determine the patient population with high risk musculoskeletal disorders. The Örebro Musculoskeletal Screening Questionnaire is a practical questionnaire that can evaluate musculoskeletal disorders and is tailored to the WHO-ICF themes. For this reason, the aim of the study is to translate the Örebro Musculoskeletal System Survey-12 into Turkish intercultural translation and to investigate the construct validity, reliability and practicality.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 319
• Est. completion date: December 18, 2024
• Est. primary completion date: December 18, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Having any musculoskeletal problems (spine, upper or lower extremities)

• Being in the age range of 18-65

Exclusion Criteria:

• Pregnancy

• Having of red flag signs.

Related Conditions & MeSH terms

• Musculoskeletal Injury

Intervention

Other:
• Orebro Musculoskeletal Screening Questionnaire-12
It is a 12-item self-report questionnaire that aims to estimate the severity of the problem, functional impairment, reporting status, cost and recovery time in musculoskeletal problems.
• Visual Analog Scale
A Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured.
• The Tampa Scale of Kinesiophobia
The Tampa Scale of Kinesiophobia that was developed in 1990 is a 17 item scale originally developed to measure the fear of movement related to chronic lower back pain.
• Short Form-12 (SF-12)
The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality of life measure.

Locations

Country	Name	City	State
Turkey	Emel Tasvuran Horata	Afyonkarahisar

Sponsors (1)

Lead Sponsor	Collaborator
Afyonkarahisar Health Sciences University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Orebro Musculoskeletal Screening Questionnaire-12	It is a 12-item self-report questionnaire that aims to estimate a wide range of outcomes (severity of the problem, functional impairment, reporting status, cost and recovery time) in patients with acute and subacute work injury presenting with musculoskeletal pain involving the spine, upper and lower extremities.	10 minutes